APP and Alzheimer disease: Thus, although HS and AD converge mechanistically on γ-secretase dysfunction, their molecular outcomes diverge: reduced enzymatic activity underlies HS pathogenesis, whereas aberrant APP processing promotes amyloid deposition and neurodegeneration in AD.